PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker

Neuroendocrine neoplasms (NENs) are rare epithelial tumors with heterogeneous and frequently unpredictable clinical behavior. Available biomarkers are insufficient to guide individual patient prognosis or therapy selection. Peptidylglycine α-amidating monooxygenase (PAM) is an enzyme expressed by ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Horton, Timothy M., Sundaram, Vandana, Lee, Christine Hye-Jin, Hornbacker, Kathleen, Van Vleck, Aidan, Benjamin, Kaisha N., Zemek, Allison, Longacre, Teri A., Kunz, Pamela L., Annes, Justin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331689/
https://www.ncbi.nlm.nih.gov/pubmed/32616904
http://dx.doi.org/10.1038/s41598-020-68071-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331689/
https://www.ncbi.nlm.nih.gov/pubmed/32616904
http://dx.doi.org/10.1038/s41598-020-68071-6

Ejemplares similares